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ABSTRACT 
 
Background: Plaque rupture is the commonest cause of myocardial infarction, occurring 
particularly in higher-risk lesions such as fibroatheromas. However, prospective virtual-
histology intravascular ultrasound (VH-IVUS) studies indicate that <10% higher-risk plaques 
cause clinical events over 3-years, indicating that other factors also determine plaque rupture. 
Plaque rupture occurs when plaque structural stress (PSS) exceeds its mechanical strength; 
however, the determinants of PSS and its association with proven plaque rupture sites are not 
known.  
 
Objectives: To identify the determinants of PSS, and the relationship between PSS and 
plaque rupture. 
 
Methods: We analyzed plaque structure and composition in 4,053 VH-IVUS frames from 32 
fibroatheromas with rupture from the VIVA study and 32 fibroatheromas without rupture on 
optical coherence tomography from a stable angina cohort. Mechanical loading in the peri-
luminal region was estimated by calculating maximum principal plaque structural stress (PSS) 
by finite element analysis.  
 
Results: PSS increased with increasing lumen area (r=0.46; p=0.001), lumen eccentricity 
(r=0.32; p=0.001), and necrotic core ≥10% (r =0.12; p=0.001), but reduced when dense 
calcium ≥10% (r =-0.12; p=0.001). Ruptured fibroatheromas showed higher PSS (133 [90-
191] vs. 104kPa [75-142]; p=0.002) and variation in PSS (55 [37-75] vs. 43kPa [34-59]; 
p=0.002) than non-ruptured fibroatheromas, with rupture primarily occurring either proximal 
or immediately adjacent to the minimal luminal area (87.5 vs. 12.5%; p=0.001). PSS was 
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higher in segments proximal to the rupture site (143 [101-200] vs. 120kPa [78-180]; p=0.001) 
vs. distal segments, associated with increased necrotic core (19.1 [11-29] vs. 14.3% [8-23]; 
p=0.001) but reduced fibrous/fibrofatty tissue (63.6 [46-78] vs. 72.7% [54-86]; p=0.001). PSS 
>135kPa was a good predictor of rupture in higher-risk regions. 
  
Conclusions: PSS is determined by plaque composition, plaque architecture, and lumen 
geometry. PSS and PSS variability are increased in plaques with rupture, particularly at 
proximal segments. Incorporating PSS into plaque assessment may improve identification of 
rupture-prone plaques. 
 
Key words: atherosclerosis, vulnerable plaque, coronary disease 
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CONDENSED ABSTRACT 
Plaque rupture is believed to occur when plaque structural stress (PSS) exceeds the material 
strength of the fibrous cap; however, the determinants of PSS and its relationship to proven 
rupture sites are unknown. We examined PSS in 4,053 VH-IVUS frames from 32 
fibroatheromas with rupture and 32 fibroatheromas without rupture. PSS increased with 
increasing lumen area, lumen eccentricity, and necrotic core ≥10%, but reduced when dense 
calcium ≥10%. Ruptured fibroatheromas showed higher PSS than non-ruptured 
fibroatheromas. PSS >135kPa was a good predictor of rupture in higher-risk regions. 
Incorporating PSS into plaque assessment may therefore improve identification of rupture-
prone plaques. 
 
 
 
LIST OF ABBREVIATIONS  
FA=fibroatheroma 
FEA = finite element analysis  
MACE = major adverse cardiovascular events  
MLA = minimal luminal area 
OCT = optical coherence tomography 
PB = plaque burden 
PSS = plaque structural stress 
VH-IVUS = virtual-histology intravascular ultrasound 
VH-FA = virtual-histology fibroatheroma 
VH-TCFA = virtual-histology thin-cap fiboratheroma 
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Introduction 
Rupture of a coronary plaque is the precipitating event in the majority of myocardial 
infarctions (MI)1. Post-mortem2 and in vivo intravascular studies3,4 identify fibroatheromas 
(FAs), and in particular thin-cap fibroatheromas (TCFAs), as the most common predisposing 
lesion.  TCFAs are widespread in human coronary artery disease, including asymptomatic 
individuals and those with stable and unstable syndromes3. However, the incidence of major 
adverse cardiovascular events (MACE) associated with TCFAs identified by virtual-histology 
intravascular ultrasound (VH-IVUS) is <10% over ~3-years follow-up3,4, suggesting that 
factors other than plaque and lumen size or plaque phenotype are important in determining 
plaque rupture.  
 
Plaque rupture occurs when intra-plaque stress exceeds the material strength of the overlying 
fibrous cap; increased plaque structural stress (PSS) is therefore a potential mechanism that 
determines rupture of a higher-risk lesion. PSS can be calculated through an engineering 
technique known as finite element analysis (FEA), which approximates a solution to the 
equations of mechanical equilibrium by considering tissue material properties, plaque 
geometry and local hemodynamic forces. Histological and VH-IVUS studies have identified 
necrotic core size, fibrous cap thickness and the presence of microcalcification as important 
determinants of PSS5-7. PSS has also been shown to be increased in patients presenting with 
acute coronary syndromes (ACS) vs. stable symptoms8. However, the determinants of PSS 
and its relationship to plaque rupture sites in vivo in human coronary arteries are not known. 
We sought to identify the parameters that determine PSS and variations in PSS across 
ruptured and non-ruptured FAs identified using VH-IVUS, to determine whether plaque stress 
is increased at plaque rupture sites, and whether incorporating PSS into plaque assessment 
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improves identification of rupture-prone plaques.
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METHODS 
Study Design 
All plaques from the VH-IVUS in Vulnerable Atherosclerosis (VIVA) study with evidence of 
rupture (n=32) on grey-scale IVUS (GS-IVUS)3 were included in the study. To compare 
ruptured vs. non-ruptured plaques, we performed optical coherence tomography (OCT) prior 
to VH-IVUS imaging on a separately recruited cohort of 40 patients with stable angina 
admitted for elective percutaneous coronary intervention (PCI)(ref 11/EE/0277). Lesions from 
this cohort were included only where there was no evidence of plaque rupture or erosion on 
VH-IVUS and OCT. As spontaneous rupture occurred only in FAs in VIVA, only VH-IVUS-
identified FAs (VH-FAs) were included in the non-ruptured group, yielding 32 plaques from 
32 patients (Fig. 1 and Online Methods).  
 
VH-IVUS and OCT Analysis 
VH-IVUS data were acquired with 20 MHz Eagle-Eye catheters (Volcano Corporation, 
Rancho, Cordova) using motorized pullback at 0.5mm/s. OCT data were acquired with 
Dragonfly C7 catheters (St. Jude Medical, St. Paul, US) using an automated pullback at 
20mm/sec. Plaque classification, identification of rupture (Fig. 2) and characterization of 
rupture location along the plaque length (Online Fig. 1) were performed as previously 
described (Online Methods). VH-IVUS plaque frames which demonstrated rupture were not 
included in the final analysis for ruptured plaques as the extreme luminal eccentricity due to 
rupture at these frames would make PSS calculations unreliable.  
 
Biomechanical Analysis 
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Plaques underwent dynamic 2D FEA simulations as previously described8 (Online Methods). 
Maximum principal stress was used to indicate the critical mechanical conditions within the 
structure, referred as PSS. A 65µm layer of fibrous tissue was introduced during mesh 
generation to account for the limited axial resolution of VH-IVUS to detect a fibrous cap 
between lumen and necrotic core/dense calcium. Examples of PSS band plots with their 
corresponding VH-IVUS images are shown in Fig. 3.  
 
Statistical Analysis 
Data were assessed for normality using the Shapiro-Wilk test. Normally distributed variables 
are presented as mean (SD) and compared using unpaired t-test, and non-normal outcomes 
presented as median (Q1-Q3) using Mann-Whitney U tests. Correlations between variables 
are expressed as Spearman correlation coefficients for non-normally distributed data. 
Multivariable regression modeling was performed to determine the independent predictors 
of PSS with purposeful selection of covariates in the cohort of VH-IVUS frames of plaque 
burden (PB) ≥70% and necrotic core >10% as these have been linked with future events3,4,9. 
Variables associated on univariate analysis (p<0.10) were included in the multivariable 
model-building process. As each plaque had multiple VH-IVUS slices, a linear mixed model 
was used to compare groups using a random effect for plaque and fixed effects for group. All 
calculations were two-tailed with p<0.05 considered statistically significant.  Statistical 
analyses were performed both in SPSS 19.0.0 (SPSS Inc., IBM Computing, US) and R 2.10.1 
(The R Foundation for Statistical Computing). 
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RESULTS 
Baseline Patient and VH-IVUS Demographics 
We analyzed PSS in patients who had spontaneous plaque rupture on GS-IVUS from the 
VIVA study (n=25 patients, n=32 plaques), compared to patients undergoing elective PCI 
where plaque rupture was excluded both by GS-IVUS and OCT (n=32 patients, n=32 
plaques)(Figs. 1 and 2). Patient demographics were similar between the ruptured and non-
ruptured groups (Table 1), with no differences in procedural systolic (129.9 vs. 123.8mmHg; 
p=0.31) or diastolic blood pressure (66.2 vs. 65.6mmHg, p=0.85).  
 
There were no significant differences in plaque classification between the 2 groups, with VH-
TCFA being the predominant plaque type accounting for rupture or undergoing PCI for stable 
angina (91 vs. 75%; p=0.14)(Table 2). PB was lower in ruptured plaques (59.5 vs. 63.5%; 
p=0.01), but minimal luminal area (MLA) and multiple components of plaque composition 
(% fibrous/fibrofatty tissue, necrotic core, dense calcium) were similar.  Patient demographics 
and plaque composition for the cohort of patients with only VH-TCFAs also did not differ 
significantly between the groups (Online Tables 1 and 2). 
 
Determinants of PSS in Virtual-histology-defined Fibroatheromas 
We used FEA to estimate both the amount and location of PSS in both ruptured and non-
ruptured plaques, and the plaque and vessel determinants of PSS. Both luminal area and 
luminal eccentricity correlated positively with PSS (r=0.46; p=0.001 and r=0.32; p=0.001, 
respectively), whereas a negative correlation was observed with PB (r=-0.23; p=0.001)(Table 
3). A positive correlation with PSS was also observed when frames with necrotic core ≥10% 
were considered (r=0.12; p=0.001)(Table 3), indicating that necrotic core only affects PSS 
when its contribution exceeds 10%. In contrast, dense calcium ≥10% and maximum arc of 
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dense calcium demonstrated negative correlations with PSS (r=-0.12 and -0.13 respectively, 
both p=0.001)(Table 3), suggesting that calcification offers a plaque ‘shielding’ effect when 
present in significant amounts. Fibrous/fibrofatty tissue was associated with PSS only when 
increasingly confluent, with no correlation seen with % tissue (r=0.02; p=0.13)(Table 3) but a 
negative correlation observed with maximum arc (r=-0.19; p=0.001). PSS varies throughout 
the cardiac cycle, with highest and lowest values corresponding to systolic and diastolic 
pressures. This cyclical stretching and relaxation may be particularly important to induce 
plaque ‘fatigue’. Indeed, PSS variability during the cardiac cycle was correlated with broadly 
similar parameters to peak PSS (Online Table 3), although fibrous/fibrofatty tissue (%) was 
negatively correlated and maximum arc of dense calcium was not correlated.  
 
Our data show that PSS is determined by a number of factors, which differ depending on 
plaque type and extent of disease. We therefore undertook regression analysis to assess 
whether individual plaque parameters could predict PSS in FAs. Although weak associations 
were observed between luminal area, plaque eccentricity, plaque burden (PB)(Figs. 4A-4C) 
and individual plaque components (Figs. 5A-5F) there were no factors that could individually 
determine PSS. 
 
PSS is likely to have the greatest clinical impact when high stress occurs in a higher risk 
region. We therefore used multivariable regression modeling to identify independent 
determinants of PSS in higher-risk segments. Luminal area, PB, % necrotic core, % dense 
calcium, fibrous/fibrofatty tissue arc, necrotic core arc, calcium arc and lumen eccentricity 
were all included in the final model. A significant regression equation was observed (F 
(8,677) = 82.1; p=0.001), with an R2 of 0.49 (R2adjusted =0.49). Luminal area (β=0.53; p=0.001), 
necrotic core arc (β=0.10; p=0.04), and lumen eccentricity (β=0.32; p=0.001) were 
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independent positive predictors of PSS, and calcium arc (β=-0.12; p=0.003) and 
fibrous/fibrofatty tissue arc (β=-0.25; p=0.001) were independent negative predictors of PSS.  
 
PSS and Plaque Rupture 
Although our data indicates that PSS is associated with plaque features considered to promote 
rupture, the relationship between PSS and plaques that demonstrate actual rupture is unclear. 
We therefore examined PSS in plaques with GS-IVUS evidence of rupture compared to 
plaques where rupture was excluded on OCT (Fig. 2). Compared to non-ruptured FAs, 
ruptured FAs showed higher PSS (133 [90-191] vs. 104kPa [75-142]; p=0.002)(Online Fig. 
2A), and this was also seen when either proximal (143 [101-200] vs. 108kPa [78-150]; 
p=0.001) or distal segments (120 [78-180] vs. 101kPa [71-138]; p=0.01) were specifically 
examined (Fig. 6A). Similarly, compared to non-ruptured FAs, ruptured FAs showed greater 
variation in PSS between systole and diastole (55 [37-75] vs. 43kPa [34-59]; p=0.02)(Online 
Fig. 2B), and this was also seen when proximal [57 [38-74] vs. 45kPa [35-60]; p=0.04) or 
distal 54 [34-75] vs. 42kPa [32-57]; p=0.01)	  segments were examined (Fig. 6B). 
 
Certain VH-IVUS features have been associated with a higher MACE risk, notably VH-
TCFA, PB ≥70% and MLA ≤4mm2, and further increased by combinations of these 
features3,4,9. PSS and variation in PSS were significantly higher in ruptured vs. non-ruptured 
VH-TCFAs (Figs. 6C and 6D), and again this was seen in both proximal and distal segments. 
Similarly, both PSS and variation in PSS were higher in plaques that were VH-TCFAs with 
PB ≥70% (PSS: 137 [95-190] vs. 80kPa [57-113]; p=0.001; variation in PSS: 54 [38-74] vs. 
37kPa [28-49]; p=0.001)(Figs. 6E and 6F), but similar between ruptured and non-ruptured 
VH-TCFAs when MLA ≤4mm2 (PSS: 88 [62-134] vs. 83kPa [59-122]; p=0.51; variation in 
PSS: 52 [33-72] vs. 38kPa [30-52]; p=0.08)(Figs. 6E and 6F). We also performed receiver 
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operating characteristic curve analysis to assess the ability of PSS to predict plaque rupture 
(Figs. 7A-7C). Inclusion of PSS significantly improved the ability of the combination of VH-
FA+PB ≥70% to identify plaque rupture (Fig. 7C). An optimal PSS cut-off of 135kPa was 
identified for this cohort, associated with good sensitivity (72.1%), specificity (83.3%), 
positive predictive (78.3%), and negative predictive (78.1%) values.  
 
Location of Plaque Rupture and Distribution of PSS in Ruptured Plaques 
The frequency of plaque rupture varies between the main coronary arteries, with left anterior 
descending (LAD) and right coronary (RCA) FAs being more prone to rupture than left 
circumflex artery (LCx) FAs, a similar pattern to coronary artery occlusion leading to ST-
elevation MI10,11. In addition, FAs in the proximal segments are particularly at risk10,12. We 
found that ruptures were more common in the RCA (59.3%), followed by LAD (40.1%) and 
LCx (15.6%), and 80% of ruptures occurred in the first 33mm of the artery. Rupture occurred 
primarily either in the proximal or middle (MLA and peri-MLA) plaque segments (87.5 vs. 
12.5%; p=0.001) in agreement with previously published data13. 
 
PSS and variations in PSS differed markedly over short distances both within the same plaque 
and between plaques, irrespective of whether these ruptured (Online Fig. 3). We therefore 
examined whether differences in PSS could explain the location of rupture, and whether this 
reflected differences in plaque composition. Both PSS (143 [101-200] vs. 120kPa [78-180]; 
p=0.001) and variation in PSS (57 [38-74] vs. 54kPa [34-75]; p=0.02) were higher in the 
segments proximal to rupture sites (Figs. 6A and 6B and Online Fig. 4) vs. distal sites. 
Proximal plaque segments comprised less fibrous/fibrofatty tissue (63.6 [46-78] vs. 72.7% 
[54-86]; p=0.001) but greater necrotic core (19.1 [11-29] vs. 14.3% [8-23]; p=0.001) and 
dense calcium (13.2 [6-25] vs. 10.1% [3-23]; p=0.001) than distal sites. Necrotic core arc (43 
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[27-66] vs. 34° [21-53]; p=0.001), calcium arc (47 [23-81] vs. 32° [14-66]; p=0.001) and 
fibrous/fibrofatty arc (144 [96-216] vs. 131° [89-191]); p=0.001) were all also increased in 
the proximal segments. PSS in the LAD/RCA arteries was higher compared to the LCx (136 
[93-195] vs. 90kPa [66-130]; p=0.01) with no differences noted in PSS variation between the 
2 vessel groups (54 [36-74] vs. 64kPa [45-80]; p=0.18). 
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Discussion  
Plaque rupture is the precipitating event in the majority of MIs, and is thought to occur at sites 
of plaque weakness1.  PSS is a potential trigger of rupture, with rupture occurring when PSS 
exceeds the mechanical strength of the overlying fibrous cap. Ex vivo carotid studies have 
shown that peak circumferential stress is highest at areas of rupture5, which has been 
confirmed by subsequent in vivo MRI studies, despite the limited capability of MRI to 
accurately identify plaque components14. However, estimation of PSS in human coronary 
plaques in vivo is more challenging. Recently we demonstrated that PSS estimated from VH-
IVUS is higher in culprit plaques of patients presenting with ACS than stable symptoms8. 
However, patients with ACS have a variety of plaque substrates and circumstances that 
account for their presentation. The current study examined the relationship between VH-
IVUS-derived PSS and proven plaque rupture compared to plaques of similar classification in 
which rupture was excluded.  
 
PSS and Plaque Architecture 
We find that PSS in coronary FAs is determined by multiple parameters, including plaque 
size, composition, and luminal geometry. PSS is increased by luminal area and eccentricity, 
but reduced by PB. PSS is increased when necrotic core is ≥10%, but reduced when dense 
calcium ≥10%. However, these relationships are complex, and none of the individual plaque 
parameters examined were able to independently determine PSS, even when considered only 
in higher-risk regions. The proximal segment of plaques also showed differences in 
composition that increase PSS compared with distal segments, including increased % necrotic 
core and decreased % fibrous/fibrofatty tissue. The observation that luminal area correlates 
positively with PSS indicates that plaques causing mild or moderate stenosis may be under 
greater stress and therefore more prone to rupture, compared to plaques that cause greater 
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lumen stenosis. This is consistent with serial coronary angiography studies that demonstrate 
that vessel occlusion, largely due to plaque rupture, often occurs at sites with less severe 
stenosis15-17.  Collectively, these results suggest that PSS is influenced by factors other than 
overall plaque composition, such as the spatial relationship between adjacent components and 
the lumen, parameters that are ignored by current classification systems of plaque 
vulnerability. 
 
PSS and Plaque Rupture 
We find that plaque rupture clusters in the RCA and LAD, and close to the coronary ostia, 
especially in the LAD10,12, similar to post-mortem studies12. We also find that proximal or 
peri-MLA plaque segments are more prone to rupture13, which are sites expected to have 
higher PSS due to their larger luminal area, in accordance with Laplace’s law (σ=Pr/h where 
σ=circumferential stress, P=intra-arterial pressure r=vessel radius and h=vessel wall 
thickness). Plaque segments proximal to the rupture site also showed higher PSS, and this was 
associated with significant differences in plaque composition. More importantly, we 
demonstrate that both PSS and variation in PSS are higher in ruptured than non-ruptured 
plaques, which was also seen when only VH-TCFAs or PB ≥70% were examined. This 
suggests that rupture occurs in a subset of higher-risk plaques already under high stress, when 
either a further increase in PSS occurs or large variations in PSS promote cap fatigue18, or 
both. PSS in the vicinity of 135kPa appears to be particularly important, a cut-off that is 
associated with good positive and negative predictive values in identifying plaques that 
demonstrate rupture. The finding that PSS did not differ between ruptured vs. non-ruptured 
plaques at sites of MLA ≤4mm2 is consistent with results from the ATHEROREMO-IVUS 
(European Collaborative Project on Inflammation and Vascular Wall Remodeling in 
	   17	  
Atherosclerosis – Intravascular Ultrasound) study, where MLA ≤4mm2 did not predict future 
MACE9.  
 
Study Limitations 
Our study has some limitations. First, although we demonstrated that ruptured plaques were 
associated with higher PSS, we cannot calculate exact PSS levels at the precise rupture site. 
Second, as PSS calculations are dependent on the resolution of VH-IVUS and its ability to 
accurately identify plaque components, PSS derived from VH-IVUS has the same limitations. 
However VH-IVUS is the only intravascular imaging modality with a) prospective clinical 
data correlating MACE with particular plaque phenotypes, b) automatic component 
identification and segmentation, thus eliminating an important source of human error and c) 
sufficient penetration to image the whole plaque, which is important for accurate PSS 
calculations. Third, our study consists of 2 cohorts that were obtained at different time points. 
However, OCT was not performed in the VIVA study, but was necessary in the unruptured 
patient population to exclude rupture, thereby ensuring that the non-ruptured group truly 
consisted of intact plaques. 
 
Conclusions 
We demonstrate that VH-IVUS-based PSS is dependent on components of plaque 
composition and plaque and lumen architecture that are also associated with plaque 
vulnerability and rupture, thereby indirectly linking PSS to plaque rupture. More importantly, 
PSS is higher in plaques with proven rupture, particularly in segments proximal to the rupture 
site, which have increased necrotic core. PSS >135kPa appears to be a good predictor of 
rupture in higher-risk regions. Our results suggest that incorporation of PSS calculations into 
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coronary plaque assessment may improve our ability to identify those plaques that proceed to 
rupture and clinical events.  
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Perspectives  
Translational Outlook: Plaque rupture is the precipitating event in the majority of 
myocardial infarctions. However, in prospective VH-IVUS studies <10% of high-risk plaques 
were responsible for cardiac events over 3 years, suggesting that other factors play a role in 
this process. Plaque structural stress (PSS) can be estimated from VH-IVUS images, and is 
proposed as a mechanism that determines rupture in high-risk regions. Incorporation of PSS 
into assessment of coronary atherosclerotic plaques may improve our ability to identify those 
that cause clinical events. 
  
 
	   20	  
 
References: 
1. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden 
cardiac ischemic death. N Engl J Med 1984; 310(18): 1137-40. 
2. Virmani R, Burke AP, Kolodgie FD, Farb A. Pathology of the thin-cap fibroatheroma: 
a type of vulnerable plaque. J Interv Cardiol 2003; 16(3): 267-72. 
3. Calvert PA, Obaid DR, O'Sullivan M, et al. Association between IVUS findings and 
adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in 
Vulnerable Atherosclerosis) Study. JACC Cardiovasc Imaging 2011; 4(8): 894-901. 
4. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of 
coronary atherosclerosis. N Engl J Med 2011; 364(3): 226-35. 
5. Richardson PD, Davies MJ, Born GV. Influence of plaque configuration and stress 
distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989; 2(8669): 941-4. 
6. Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on 
peak circumferential stress in model atherosclerotic vessels. Circ Res 1992; 71(4): 850-8. 
7. Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT. The impact of 
calcification on the biomechanical stability of atherosclerotic plaques. Circulation 2001; 
103(8): 1051-6. 
8. Teng Z, Brown AJ, Calvert PA, et al. Coronary Plaque Structural Stress Is Associated 
With Plaque Composition and Subtype and Higher in Acute Coronary Syndrome: The 
BEACON I (Biomechanical Evaluation of Atheromatous Coronary Arteries) Study. Circ 
Cardiovasc Imaging 2014; 7(3): 461-70. 
9. Cheng JM, Garcia-Garcia HM, de Boer SP, et al. In vivo detection of high-risk 
coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: 
results of the ATHEROREMO-IVUS study. European Heart Journal 2014; 35(10): 639-47. 
	   21	  
10. Hong MK, Mintz GS, Lee CW, et al. The site of plaque rupture in native coronary 
arteries: a three-vessel intravascular ultrasound analysis. J Am Coll Cardiol 2005; 46(2): 261-
5. 
11. Wang JC, Normand SL, Mauri L, Kuntz RE. Coronary artery spatial distribution of 
acute myocardial infarction occlusions. Circulation 2004; 110(3): 278-84. 
12. Cheruvu PK, Finn AV, Gardner C, et al. Frequency and distribution of thin-cap 
fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll 
Cardiol 2007; 50(10): 940-9. 
13. Fukumoto Y, Hiro T, Fujii T, et al. Localized elevation of shear stress is related to 
coronary plaque rupture: a 3-dimensional intravascular ultrasound study with in-vivo color 
mapping of shear stress distribution. J Am Coll Cardiol 2008; 51(6): 645-50. 
14. Tang D, Teng Z, Canton G, et al. Sites of rupture in human atherosclerotic carotid 
plaques are associated with high structural stresses: an in vivo MRI-based 3D fluid-structure 
interaction study. Stroke 2009; 40(10): 3258-63. 
15. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict 
the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary 
artery disease? Circulation 1988; 78(5 Pt 1): 1157-66. 
16. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of 
coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 
1988; 12(1): 56-62. 
17. Giroud D, Li JM, Urban P, Meier B, Rutishauer W. Relation of the site of acute 
myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J 
Cardiol 1992; 69(8): 729-32. 
18. Teng Z, Sadat U, Huang Y, et al. In vivo MRI-based 3D mechanical stress-strain 
profiles of carotid plaques with juxtaluminal plaque haemorrhage: an exploratory study for 
	   22	  
the mechanism of subsequent cerebrovascular events. Eur J Vasc Endovasc Surg 2011; 42(4): 
427-33. 
 
	   23	  
 
Figure Legends 
Figure 1. Schematic representation of patient and plaque populations included in the 
study 
FEA=finite element analysis; OCT=optical coherence tomography; VH-FA=virtual-histology 
fibroatheroma; VIVA=VH-IVUS in Vulnerable Atherosclerosis study.  
 
Figure 2. Identification of plaque rupture using grey-scale intravascular ultrasound and 
optical coherence tomography  
(A-B) Grey-scale IVUS images of spontaneous plaque rupture (*). (C) OCT image showing 
evidence of rupture (*). (D) Thin-cap fibroatheroma (arrow) as identified by OCT with no 
evidence of rupture or erosion. (E) Longitudinal IVUS reconstruction of a coronary artery 
with evidence of plaque rupture (proximal (A’), rupture site (B’) and distal (C’) segments). 
IVUS=intravascular ultrasound; OCT=optical coherence tomography. 
 
Figure 3. Illustrative examples for stepwise calculation of plaque structural stress from 
virtual-histology intravascular ultrasound through finite element analysis  
(A and D) VH-IVUS images showing necrotic core (red), dense calcium (white), fibrofatty 
tissue (light green) and fibrous (green). (B and E) Reconstructed plaque geometry and 
segmented plaque components used for FEA. (C and F) PSS band plots identifying regions 
with high stress concentration (arrows indicate areas of high stress at the plaque/lumen 
boundary). FEA=finite element analysis; PSS=plaque structural stress; VH-IVUS=virtual-
histology ultrasound. 
 
Figure 4. Indices of vessel geometry and plaque structural stress  
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(A-C) Regression curves illustrating best-fit relationships between PSS and (A) luminal area, 
(B) luminal eccentricity or (C) plaque burden. PSS=plaque structural stress. 
 
Figure 5. Effect of plaque components on plaque structural stress  
(A-F) Regression curves illustrating best-fit relationships between PSS and (A) necrotic core 
(%), (B) maximal arc of necrotic core (°), (C) dense calcium (%), (D) maximal arc of dense 
calcium (°), (E) fibrous/fibrofatty tissue (%), and (F) maximal arc of fibrous/fibrofatty tissue 
(°). PSS=plaque structural stress. 
 
Figure 6.  Plaque structural stress and variation in PSS in virtual-histology 
fibroatheromas with and without rupture 
(A and B) PSS and variation in PSS in the proximal and distal segments of VH-FAs with and 
without plaque rupture. (C and D) PSS and variation in PSS in the proximal and distal 
segments of VH-TCFAs with and without PR. (E and F) PSS and variation in PSS in VH-
TCFAs with PB ≥70% or MLA ≤4mm2 with and without PR. MLA=minimal luminal area; 
PR=plaque rupture; PSS=plaque structural stress; VH-FA=virtual-histology fibroatheroma; 
VH-TCFA=virtual-histology thin-cap fibroatheroma. 
 
Figure 7. Receiver operating characteristic curves illustrating the discriminatory power 
of PSS to identify plaque rupture 
(A) ROC curve for PSS in VH-FA (B) ROC curve for PSS in VH-FA+MLA ≤4mm2, and (C) 
ROC curve for PSS in VH-FA+PB ≥70%. AUC=area under the curve; CI=confidence 
interval; MLA=minimal lumen area; PB=plaque burden; ROC=receiver operating 
characteristic; VH-FA=virtual-histology fibroatheroma. 
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Table 1. Demographics of patients with ruptured and non-ruptured plaques  
Characteristic Ruptured 
(n=25) 
Non-ruptured 
(n=32) 
p-value 
Age, y 61.4 (10.4) 64.0 (10.1) 0.46 
Male, n (%) 20 (80) 29 (90.6) 0.25 
Diabetes mellitus, n (%) 2 (8) 6 (18.8) 0.25 
Hypertension, n (%) 9 (36) 10 (31.3) 0.71 
Hypercholesterolemia, n (%)  8 (32) 6 (18.8) 0.25 
Smoker, n (%)  8 (32) 6 (18.8) 0.25 
Family history of CAD, n (%) 14 (56) 12 (37.5) 0.43 
Procedural blood pressure    
     Systolic blood pressure, mm Hg 129.9 (25.1) 123.8 (18.9) 0.31 
     Diastolic blood pressure, mm Hg 66.2 (8.5) 65.6 (9.3) 0.85 
Total cholesterol, mmol/L 3.57 (0.88) 3.83 (0.97) 0.35 
LDL cholesterol, mmol/L 2.37 (0.84) 2.68 (0.98) 0.25 
HDL cholesterol, mmol/L 1.21 (0.47) 1.15 (0.26) 0.60 
Total cholesterol:HDL ratio 3.34 (1.62) 3.51 (1.47) 0.72 
Creatinine, mg/DL 85.6 (17.5) 94.9 (22.5) 0.11 
hsCRP, mg/L 11.6 (28.9) 5.36 (8.8) 0.26 
Data are shown as mean (SD) or n (%). CAD=coronary artery disease; hsCRP=high-
sensitivity C-reactive protein; HDL=high-density lipoprotein; LDL=low-density 
lipoprotein; MI=myocardial infarction 
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Tabl
e 2. 
VH-
IVU
S 
para
mete
rs of 
rupt
ured 
and 
non-
rupt
ured 
plaq
ues 
 
 
 
Characteristic Ruptured 
(n=32) 
Non-Ruptured 
(n=32) 
p-value 
VH-TCFA, n (%) 29 (90.6) 24 (75) 0.14 
Plaque burden, n (%) 58.2 (6.8) 63.5 (4.8) 0.01 
Minimal luminal area ≤4mm2, n (%) 30 (93.8) 32 (100) 0.14 
Fibrous/fibrofatty, n (%) 60.8 (54-70) 67.5(60-75) 0.10 
Necrotic core, (%) 18.9 (15-27) 18.3 (14-23) 0.46 
Dense calcium, (%) 15.8 (11-24) 14.1 (7-22) 0.33 
Plaque characteristics at frame level    
Fibrous/fibrofatty, (%) 67.5  (50-82) 69.1 (50-84) 0.44 
Necrotic core, (%) 16.5 (9-26) 15.6 (9-26) 0.18 
Dense calcium, (%) 11.8 (4-24) 11.2 (4-25) 0.58 
Maximum arc of fibrous/fibrofatty 
tissue, (°) 
137.3 (93-205) 140.3 (94-205) 0.24 
Maximum arc of necrotic core, (°) 38.5 (25-60) 37.1 (22-57) 0.18 
Maximum arc of dense calcium, (°) 40.5(18-76) 37.1 (18-64) 0.12 
Lumen eccentricity 0.51 (0.4-0.6) 0.5 (0.4-0.6) 0.38 
Data shown are n (%), mean (SD) or median (Q1–Q3). VH-IVUS=virtual-histology 
intravascular ultrasound; VH-TCFA=virtual-histology thin-cap fibroatheroma 
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Table 
3. 
Correl
ation 
coeffici
ents 
betwee
n PSS 
and 
VH-
IVUS 
param
eters 
Characteristic Correlation coefficient (r) p-value 
Luminal area, (mm2) 0.46 0.001 
Plaque burden, (%) -0.23 0.001 
Lumen eccentricity 0.32 0.001 
Necrotic core ≥10, (%) 0.12 0.001 
Maximum arc of necrotic core, (°) 0.01 0.70 
Dense calcium ≥10, (%) -0.12 0.001 
Maximum arc of dense calcium, (°) -0.13 0.001 
Fibrous/fibrofatty tissue, (%) 0.02 0.13 
Maximum arc of fibrous/fibrofatty tissue, (°) -0.19 0.001 
PSS=plaque structural stress; VH-IVUS=virtual-histology intravascular ultrasound 
1808 VH-IVUS frames 
outside actual rupture site 
underwent further analysis  
(plaque number=32) 
2245 VH-IVUS frames 
underwent further analysis 
(plaque number=32) 
VH-IVUS frames from 
vessels with evidence of 
plaque rupture on GS-
IVUS underwent FEA 
(n=3583 frames) 
VH-IVUS frames from 
vessels with VH-FA and 
no evidence of rupture 
on OCT underwent FEA 
(n=3794 frames) 
Frames outside regions of 
interest were excluded from final 
analysis (n=3324) 
170 patients from the 
VIVA study underwent 3-
vessel VH-IVUS  
40 patients underwent 
baseline VH-IVUS and 
OCT imaging  
Ruptured   Non-Ruptured  
Figure 1. Schematic representation of patient and plaque populations included in 
the study 
FEA=finite element analysis; OCT=optical coherence tomography; VH-FA=virtual-
histology fibroatheroma; VIVA=VH-IVUS in Vulnerable Atherosclerosis study.  
Figure 1 
A B 
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Figure 2. Identification of plaque rupture using grey-scale intravascular 
ultrasound and optical coherence tomography  
(A-B) Grey-scale IVUS images of spontaneous plaque rupture (*). (C) OCT image 
showing evidence of rupture (*). (D) Thin-cap fibroatheroma (arrow) as identified by 
OCT with no evidence of rupture or erosion. (E) Longitudinal IVUS reconstruction of a 
coronary artery with evidence of plaque rupture (proximal (A’), rupture site (B’) and distal 
(C’) segments). IVUS=intravascular ultrasound; OCT=optical coherence tomography. 
Figure 2 
A B
C D
* 
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Figure 3 
Figure 3. Illustrative examples for stepwise calculation of plaque structural stress 
from virtual-histology intravascular ultrasound through finite element analysis  
(A and D) VH-IVUS images showing necrotic core (red), dense calcium (white), fibrofatty 
tissue (light green) and fibrous (green). (B and E) Reconstructed plaque geometry and 
segmented plaque components used for FEA. (C and F) PSS band plots identifying regions 
with high stress concentration (arrows indicate areas of high stress at the plaque/lumen 
boundary). FEA=finite element analysis; PSS=plaque structural stress; VH-IVUS=virtual-
histology ultrasound. 
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Figure 4. Indices of vessel geometry and plaque structural stress  
(A-C) Regression curves illustrating best-fit relationships between PSS and (A) 
luminal area, (B) luminal eccentricity or (C) plaque burden. PSS=plaque 
structural stress. 
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Figure 5 
Figure 5. Effect of plaque components on plaque structural stress  
(A-F) Regression curves illustrating best-fit relationships between PSS and (A) necrotic core 
(%), (B) maximal arc of necrotic core (°), (C) dense calcium (%), (D) maximal arc of dense 
calcium (°), (E) fibrous/fibrofatty tissue (%), and (F) maximal arc of fibrous/fibrofatty tissue (°). 
PSS=plaque structural stress. 
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 Figure 6.  Plaque structural stress and variation in PSS in virtual-histology 
fibroatheromas with and without rupture 
(A and B) PSS and variation in PSS in the proximal and distal segments of VH-FAs with and 
without plaque rupture. (C and D) PSS and variation in PSS in the proximal and distal 
segments of VH-TCFAs with and without PR. (E and F) PSS and variation in PSS in VH-
TCFAs with PB ≥70% or MLA ≤4mm2 with and without PR. MLA=minimal luminal area; 
PB=plaque burden; PR=plaque rupture; PSS=plaque structural stress; VH-FA=virtual-histology 
fibroatheroma; VH-TCFA=virtual-histology thin-cap fibroatheroma. 
Figure 7. Receiver operating characteristic curves illustrating the discriminatory power of 
PSS to identify plaque rupture 
(A) ROC curve for PSS in VH-FA (B) ROC curve for PSS in VH-FA+MLA ≤4mm2, and (C) ROC 
curve for PSS in VH-FA+PB ≥70%. AUC=area under the curve; CI=confidence interval; 
MLA=minimal lumen area; PB=plaque burden; ROC=receiver operating characteristic; VH-
FA=virtual-histology fibroatheroma. 
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